Browsing byAuthorGreenfield, JR

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
2023-09Associations of Type 2 Diabetes, Body Composition, and Insulin Resistance with Bone Parameters: The Dubbo Osteoporosis Epidemiology Study.Sheu, A; Blank, RD; Tran, T; Bliuc, D; Greenfield, JR; White, CP; Center, JR
2022-12-20Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists.Raven, LM; Muir, CA; Macdonald, PS; Hayward, CS; Jabbour, A; Greenfield, JR
2019-05Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients.Cehic, MG; Muir, CA; Greenfield, JR; Hayward, C; Jabbour, A; Keogh, A; Kotlyar, E; Muthiah, K; Macdonald, PS
2023-09Metabolic Sequelae of Everolimus Treatment After Cardiac Transplant: A Hypothesis-Generating Study.Raven, LM; Muir, CA; Pouliopoulos, J; Hayward, CS; Macdonald, PS; Greenfield, JR; Jabbour, A
2023-11-15Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices.Chavali, S; Barua, S; Adji, A; Robson, D; Raven, LM; Greenfield, JR; Eckford, H; Macdonald, PS; Hayward, CS; Muthiah, K
2023-03-29Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial.Raven, LM; Muir, CA; Kessler Iglesias, C; Bart, NK; Muthiah, K; Kotlyar, E; Macdonald, P; Hayward, CS; Jabbour, A; Greenfield, JR
2023-08The safe use of metformin in heart failure patients both with and without T2DM: A cross-sectional and longitudinal study.Chowdhury, G; Carland, JE; Kumar, S; Olsen, N; Graham, G; Kumarasinghe, G; Hayward, CS; Greenfield, JR; Macdonald, P; Day, RO; Stocker, SL